SCHEMBL30846509

SCHEMBL30846509

COc1cc2ncnc(N(C)c3cccc(Br)c3)c2cc1OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 18/20 1.00
▸ CSF1R P07333 15/20 0.76
▸ KDR P35968 3/20 0.74
▸ RET P07949 1/20 0.74
▸ KIF5B P33176 1/20 0.74
▸ PDGFRB P09619 1/20 0.73
▸ PDGFRA P16234 1/20 0.73
▸ ERBB2 P04626 2/20 0.55
▸ KDM4E B2RXH2 1/20 0.55
▸ GAK O14976 1/20 0.55
▸ MAPK13 O15264 1/20 0.55
▸ ABL1 P00519 1/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CDK1 P06493 1/20 0.55
▸ CYP3A4 P08684 1/20 0.55
▸ FBP1 P09467 1/20 0.55
▸ CYP2D6 P10635 1/20 0.55
▸ MAPT P10636 1/20 0.55
▸ CYP2C9 P11712 1/20 0.55
▸ SRC P12931 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2257706 0.85 CSF1R (1.00) EGFRCSF1RKDRRETKIF5B
SCHEMBL6181700 0.85 EGFR (1.00) EGFRCSF1RKDRRETKIF5B
Hydrochloric Acid SCHEMBL6179746 0.84 CSF1R (1.00) EGFRCSF1RKDRRETKIF5B
Hydrochloric Acid SCHEMBL6180093 0.84 EGFR (1.00) EGFRCSF1RKDRRETKIF5B
SCHEMBL27662120 0.82 EGFR (0.70) EGFRCSF1RKDRRETKIF5B
SCHEMBL6181635 0.82 EGFR (1.00) EGFRCSF1RKDRRETKIF5B
SCHEMBL27641671 0.82 EGFR (0.69) EGFRCSF1RKDRRETKIF5B
Hydrochloric Acid SCHEMBL6180417 0.81 EGFR (1.00) EGFRCSF1RKDRRETKIF5B
SCHEMBL6836525 0.80 EGFR (0.67) EGFRCSF1RKDRRETKIF5B
SCHEMBL6183306 0.79 CSF1R (1.00) EGFRCSF1RKDRRETKIF5B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4578457-A1 PHARMACEUTICAL FOR TREATING AND/OR PREVENTING CANCER Toray Industries, Inc. (JP) 2025-07-02 — — EP disclosed
CN-119768182-A Medicine for treating and/or preventing cancer 东丽株式会社 2025-04-04 — — CN disclosed
WO-2024178274-A2 METHODS OF DEGRADING RAF(RAF) PROTEIN IN CELLS USING MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1/2 (MEK1/2) PROTEIN DEGRADERS INSTITUTE FOR CANCER RESEARCH D/B/A THE RESEARCH INSTITUTE OF FOX CHASE CANCER CENTER (US) 2024-08-29 — — WO disclosed
WO-2024043252-A1 PHARMACEUTICAL FOR TREATING AND/OR PREVENTING CANCER 東レ株式会社 2024-02-29 — — WO disclosed
Send feedback